Triple

T19773076
Position Surface form Disambiguated ID Type / Status
Subject Xeljanz E474935 entity
Predicate targets P860 FINISHED
Object Janus kinase 1 NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Janus kinase 1 | Statement: [Xeljanz, targets, Janus kinase 1]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Janus kinase 1
Context triple: [Xeljanz, targets, Janus kinase 1]
  • A. Bruton tyrosine kinase
    Bruton tyrosine kinase is a key signaling enzyme in B cells that plays a crucial role in their development and function and is a major therapeutic target in certain blood cancers and autoimmune diseases.
  • B. JAK-STAT signaling pathway
    The JAK-STAT signaling pathway is a key intracellular cascade that transmits signals from cell-surface receptors to the nucleus to regulate gene expression involved in cell growth, differentiation, immune function, and survival.
  • C. IL-64
    IL-64 is a major east–west state highway in Illinois that runs from the Mississippi River through the Chicago metropolitan area.
  • D. PLCγ2
    PLCγ2 is a phospholipase C isoform that functions as a key signaling enzyme in immune cells, mediating receptor-induced calcium mobilization and downstream activation pathways.
  • E. IL-17A
    IL-17A is a pro-inflammatory cytokine produced mainly by Th17 cells that plays a key role in the pathogenesis of several autoimmune and inflammatory diseases.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Janus kinase 1
Target entity description: Janus kinase 1 is a tyrosine kinase enzyme involved in cytokine receptor signaling and immune regulation, making it an important therapeutic target in inflammatory and autoimmune diseases.
  • A. Bruton tyrosine kinase
    Bruton tyrosine kinase is a key signaling enzyme in B cells that plays a crucial role in their development and function and is a major therapeutic target in certain blood cancers and autoimmune diseases.
  • B. JAK-STAT signaling pathway
    The JAK-STAT signaling pathway is a key intracellular cascade that transmits signals from cell-surface receptors to the nucleus to regulate gene expression involved in cell growth, differentiation, immune function, and survival.
  • C. IL-64
    IL-64 is a major east–west state highway in Illinois that runs from the Mississippi River through the Chicago metropolitan area.
  • D. PLCγ2
    PLCγ2 is a phospholipase C isoform that functions as a key signaling enzyme in immune cells, mediating receptor-induced calcium mobilization and downstream activation pathways.
  • E. IL-17A
    IL-17A is a pro-inflammatory cytokine produced mainly by Th17 cells that plays a key role in the pathogenesis of several autoimmune and inflammatory diseases.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8e51a43a08190956bc6df13c91a77 completed April 10, 2026, 11:55 a.m.
NER Named-entity recognition batch_69e6535e450c8190a2628245ae0d0bd3 completed April 20, 2026, 4:25 p.m.
Created at: April 10, 2026, 1:48 p.m.